Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc > Here we go

<< Previous

Bullboard Posts

Next >>

Comment by Northforce13on Nov 29, 2021 4:23pm

141 Views

Post# 34177385

RE:Here we go

Dunno lol! Never thought I'd see it at these prices. At this rate we could be back to 1.00 by year end ;-)

Bought a bit more at 1.75 in my TFSA

I have been toying with the idea of selling some of my larger holdings to pile into CPH ever since it went to < 2.25. Tax reasons make me very reluctant to do so but it is increasingly tempting.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec